Find the right asset, faster
Run diligence, map competitive landscapes, and prioritize assets with evidence, IP, and market context in one workflow.
From diligence to decision memo
See how EMET supports business development teams focused on diligence, competitive mapping, and asset prioritization.
Business development capabilities
Explore a range of sample prompts and representative outputs from EMET across the workflows below.
Score STAT6 as a potential in-licensing target for atopic dermatitis - assess genetic evidence, disease expression, druggability, essentiality, and existing competitive compounds.
pharos-targetsopentargets-associationsgwas-associationsdepmap-dependencychembl-bioactivities
Drug programs fail when biology is misunderstood. EMET exists to close that gap — before it closes your pipeline.
Request a Demo